@article{denhamShorttermAndrogenSuppression2014,
 annotation = {88 citations (Crossref) [2022-07-10]},
 author = {Denham, JW and Joseph, D and Lamb, DS and Spry, NA and Duchesne, G and Matthews, J and Atkinson, C and Tai, K-H and Christie, D and Kenny, L and Turner, S and Gogna, NK and Diamond, T and Delahunt, B and Oldmeadow, C and Attia, J and Steigler, A},
 copyright = {All rights reserved},
 journal = {Lancet Oncol},
 keywords = {clinical trial,Prostate cancer,RCT,Zoledronic Acid},
 langid = {english},
 month = {September},
 number = {10},
 pages = {1076--1089},
 title = {Short-Term Androgen Suppression and Radiotherapy versus Intermediate-Term Androgen Suppression and Radiotherapy, with or without Zoledronic Acid, in Men with Locally Advanced Prostate Cancer (TROG 03.04 RADAR): An Open-Label, Randomised, Phase 3 Factorial Trial.},
 volume = {15},
 year = {2014}
}

